FMED vs. FSMEX
Compare and contrast key facts about Fidelity Disruptive Medicine ETF (FMED) and Fidelity Select Medical Technology and Devices Portfolio (FSMEX).
FMED is an actively managed fund by Fidelity. It was launched on Apr 16, 2020. FSMEX is managed by Fidelity. It was launched on Apr 28, 1998.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FMED or FSMEX.
Key characteristics
| FMED | FSMEX | |
|---|---|---|
| YTD Return | 8.76% | 10.93% |
| 1Y Return | 30.60% | 33.72% |
| Sharpe Ratio | 1.70 | 1.94 |
| Sortino Ratio | 2.42 | 2.70 |
| Omega Ratio | 1.30 | 1.34 |
| Calmar Ratio | 1.29 | 0.72 |
| Martin Ratio | 7.58 | 7.25 |
| Ulcer Index | 3.58% | 4.23% |
| Daily Std Dev | 15.92% | 15.83% |
| Max Drawdown | -21.84% | -43.45% |
| Current Drawdown | -0.86% | -23.07% |
Correlation
The correlation between FMED and FSMEX is 0.87, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
FMED vs. FSMEX - Performance Comparison
In the year-to-date period, FMED achieves a 8.76% return, which is significantly lower than FSMEX's 10.93% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FMED vs. FSMEX - Expense Ratio Comparison
FMED has a 0.50% expense ratio, which is lower than FSMEX's 0.68% expense ratio.
Risk-Adjusted Performance
FMED vs. FSMEX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Disruptive Medicine ETF (FMED) and Fidelity Select Medical Technology and Devices Portfolio (FSMEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FMED vs. FSMEX - Dividend Comparison
Neither FMED nor FSMEX has paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FMED Fidelity Disruptive Medicine ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FSMEX Fidelity Select Medical Technology and Devices Portfolio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 11.71% | 5.17% | 9.84% |
Drawdowns
FMED vs. FSMEX - Drawdown Comparison
The maximum FMED drawdown since its inception was -21.84%, smaller than the maximum FSMEX drawdown of -43.45%. Use the drawdown chart below to compare losses from any high point for FMED and FSMEX. For additional features, visit the drawdowns tool.
Volatility
FMED vs. FSMEX - Volatility Comparison
The current volatility for Fidelity Disruptive Medicine ETF (FMED) is 3.51%, while Fidelity Select Medical Technology and Devices Portfolio (FSMEX) has a volatility of 4.09%. This indicates that FMED experiences smaller price fluctuations and is considered to be less risky than FSMEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.